Clinical relevance of antibodies to HLA antigens undetectable by the standard complement-dependent cytotoxicity test

Transpl Int. 2003 Dec;16(12):872-8. doi: 10.1007/s00147-003-0642-y. Epub 2003 Aug 2.

Abstract

Recent literary data suggest that antibodies to HLA antigens undetectable by the standard complement-dependent cytotoxicity test may cause not only chronic, but also acute immunological complications after kidney transplantation. The aim of this study was to investigate the significance of non-cytotoxic antibodies to HLA antigens for the development of immunological complications and a worse graft prognosis after first kidney transplantation. Sera before and early after transplantation from 120 first kidney recipients were analyzed by flow cytometry (FCXM), ELISA and the standard complement-dependent cytotoxicity (CDC) test. Pre-transplant FCXM negativity was related to a lower incidence of rejection episodes in the first post-transplant year ( P<0.01). A significant association between acute rejection and the presence of antibodies to HLA class II antigens before and after transplantation was also found ( P<0.05). Our study supports the findings of other centers of the detrimental role to the kidney graft played by anti-HLA antibodies undetectable by the classical CDC test.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoantibodies / analysis
  • Autoantibodies / blood
  • Autoantibodies / immunology*
  • Complement System Proteins
  • Cytotoxicity Tests, Immunologic
  • Enzyme-Linked Immunosorbent Assay
  • Epitopes
  • Flow Cytometry
  • Graft Rejection / diagnosis*
  • Graft Rejection / immunology
  • Graft Rejection / mortality
  • Graft Survival / immunology
  • HLA Antigens / immunology*
  • Humans
  • Prognosis
  • Transplantation Immunology*

Substances

  • Autoantibodies
  • Epitopes
  • HLA Antigens
  • Complement System Proteins